Rezolute Stock (NASDAQ: RZLT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 356.870K |
Day Range | - - - |
52 Wk Range | 0.720 - 3.690 |
Market Cap | $146.426M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 79 |
Short Interest | 1.49% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rezolute (NASDAQ: RZLT) through any online brokerage.
Other companies in Rezolute’s space includes: Zura Bio (NASDAQ:ZURA), Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), Vistagen Therapeutics (NASDAQ:VTGN) and Adicet Bio (NASDAQ:ACET).
The latest price target for Rezolute (NASDAQ: RZLT) was reported by JMP Securities on Friday, April 19, 2024. The analyst firm set a price target for 7.00 expecting RZLT to rise to within 12 months (a possible 91.83% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Rezolute (NASDAQ: RZLT) is $3.649 last updated April 22, 2024 at 7:26 PM EDT.
There are no upcoming dividends for Rezolute.
Rezolute’s Q3 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Rezolute.
Rezolute is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.